4.13

2.36% -0.10

Pre-market: 4.20 0.07 +1.69%

Orchestra Biomed Holdings Inc (OBIO)

Overview News Price History Discussions Forecast

Orchestra Biomed Holdings Inc stock is traded at $4.13, with a volume of 106.10K. It is down -2.36% in the last 24 hours and down -10.99% over the past month. Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Previous Close:

$4.23

Open:

$4.23

24h Volume:

106.10K

Relative Volume:

0.51

Market Cap:

$241.69M

Revenue:

$33.48M

Net Income/Loss:

$-52.70M

P/E Ratio:

-3.2043

EPS:

-1.2889

Net Cash Flow:

$-49.45M

1W Performance:

-3.28%

1M Performance:

-10.99%

6M Performance:

+31.11%

1Y Performance:

+58.85%

1-Day Range:

$4.10

$4.318

1-Week Range:

$4.10

$4.47

52-Week Range:

$2.20

$5.424

Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile

Name

Orchestra Biomed Holdings Inc

Sector

Healthcare (1105)

Industry

Biotechnology (623)

Phone

646-343-9298

Address

150 UNION SQUARE DRIVE, NEW HOPE

Employee

Twitter

Next Earnings Date

2026-03-30

Latest SEC Filings

OBIO's Discussions on Twitter

Compare OBIO vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OBIO Orchestra Biomed Holdings Inc	4.13	241.69M	33.48M	-52.70M	-49.45M	-1.2889
VRTX Vertex Pharmaceuticals Inc	436.27	110.97B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	748.87	79.17B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	799.65	49.73B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	322.11	42.98B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	309.66	34.37B	5.36B	287.73M	924.18M	2.5229

Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-10-25	Initiated	TD Cowen	Buy
Aug-20-25	Downgrade	BTIG Research	Buy → Neutral
Mar-20-25	Initiated	BTIG Research	Buy
Jan-02-25	Initiated	Barclays	Overweight
Aug-22-24	Initiated	H.C. Wainwright	Buy
Jul-25-24	Initiated	B. Riley Securities	Buy
Jan-19-24	Initiated	Jefferies	Buy
Feb-24-23	Initiated	Piper Sandler	Overweight
Feb-07-23	Initiated	Chardan Capital Markets	Buy

View All

Orchestra Biomed Holdings Inc Stock (OBIO) Latest News

Apr 12, 2026

Orchestra BioMed Holdings (OBIO) price target decreased by 11.17% to 11.39 - MSN

Apr 12, 2026

Apr 11, 2026

OBIO Options Volatility — NASDAQ:OBIO - TradingView — Track All Markets

Apr 11, 2026

OBIO Options Chain — NASDAQ:OBIO - TradingView — Track All Markets

Apr 11, 2026

Apr 09, 2026

How sensitive is Orchestra BioMed Holdings Inc to inflation2026 Market Outlook & Verified High Yield Trade Plans - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

If You Invested $1,000 in Orchestra BioMed Holdings Inc (OBIO) - Stock Titan

Apr 08, 2026

Apr 06, 2026

Orchestra BioMed : April 2026 Corporate Presentation - marketscreener.com

Apr 06, 2026

Apr 02, 2026

Orchestra Biomed Holdings Inc (NASDAQ:OBIO) Fits the Minervini High-Growth Momentum Template - ChartMill

Apr 02, 2026

Mar 30, 2026

Aug Fed Impact: What is Orchestra BioMed Holdings Incs 5 year growth outlook - baoquankhu1.vn

Mar 30, 2026

Activity Recap: Does Orchestra BioMed Holdings Inc outperform in volatile markets2026 Market WrapUp & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 28, 2026

Analyst Upgrade: How much upside does Orchestra BioMed Holdings Inc have2026 Chart Watch & Free Verified High Yield Trade Plans - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

Orchestra BioMed reports 2025 results, advances pivotal clinical trials - MSN

Mar 27, 2026

Orchestra BioMed (NASDAQ: OBIO) insider reports RSU tax withholding event - Stock Titan

Mar 27, 2026

Orchestra BioMed (OBIO) officer has shares withheld for RSU tax payment - Stock Titan

Mar 27, 2026

Orchestra BioMed (OBIO) insider withholds 32,438 RSU shares for tax - Stock Titan

Mar 27, 2026

Mar 26, 2026

Stock Report: Does Orchestra BioMed Holdings Inc outperform in volatile markets2026 Opening Moves & Technical Analysis for Trade Confirmation - baoquankhu1.vn

Mar 26, 2026

Jefferies cuts Orchestra BioMed stock price target on financing costs By Investing.com - Investing.com Australia

Mar 26, 2026

Mar 25, 2026

Orchestra BioMed (OBIO) to Release Earnings on Wednesday - MarketBeat

Mar 25, 2026

Mar 22, 2026

Trend Report: How do insiders feel about Orchestra BioMed Holdings IncRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 22, 2026

Mar 20, 2026